ENCORE ENERGY CORP. (EU) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 12.94%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 12.94% | Share-based compensation / revenue. Period ending 2026-06-30. $7.15M ÷ $55.25M × 100 ≈ 12.94% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 55.25M USD | |
| Stock-based compensation | 7.15M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -50.40M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $55.25M | $7.15M | $-50.40M | (m) | (m) | 12.94% | (m) | (m) |
| 2026-03-31 | (m) | $43.22M | $5.70M | $-40.18M | (m) | (m) | 13.19% | (m) | (m) |
| 2025-12-31 | (m) | $43.16M | $4.20M | $-65.77M | (m) | (m) | 9.74% | (m) | (m) |
| 2025-09-30 | (m) | $44.14M | $3.56M | $-68.52M | (m) | (m) | 8.07% | (m) | (m) |
| 2025-06-30 | (m) | $44.52M | $4.71M | $-71.84M | (m) | (m) | 10.59% | (m) | (m) |
| 2025-03-31 | (m) | $46.18M | $4.85M | $-75.53M | (m) | (m) | 10.50% | (m) | (m) |
| 2024-12-31 | (m) | $58.33M | $4.79M | $-72.18M | (m) | (m) | 8.21% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $22.15M | $3.46M | $-40.72M | (m) | (m) | 15.64% | (m) | (m) |
| 2022-12-31 | (m) | $4.25M | $4.33M | $-25.91M | (m) | (m) | 102.05% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eagle Nuclear Energy Corp. (NUCL) | United States | $0.180B | |
| URANIUM ENERGY CORP (UEC) | $4.686B | -70.71 |